Biren Amin

Sr. Research Analyst
Sector Expertise
Additional Expertise
Biren Amin is a managing director and senior research analyst on the healthcare equity research team covering biotechnology companies. Prior to joining Piper Sandler, Amin served as the chief financial officer and chief strategy officer at Pyramid Biosciences, a private biotechnology company, where he was responsible for investor relations, capital raising and leading business development activities including monitoring key competitors for therapeutics targeting solid tumors. Before Pyramid Biosciences, Amin served as the chief financial officer at Immuneering Corporation, a public clinical-stage oncology company. He previously spent 10 years at Jefferies Financial Group Inc. covering small and mid-cap biotechnology companies focused on oncology, central nervous system disorders, ophthalmology and rare diseases. Prior to Jefferies Financial Group Inc., Amin spent seven years in various equity research roles covering the biotechnology sector. Amin graduated from University of the Sciences with a bachelor's degree in pharmacy. He received his master's degree from Long Island University and his Master of Business Administration degree from the Leonard Stern School of New York University.

Universe Coverage

ALLOAllogene Therapeutics, Inc.
APLSApellis Pharmaceuticals, Inc.
ACLXArcellx, Inc.
CRGXCargo Therapeutics, Inc.
ELEVElevation Oncology, Inc.
IMNMImmunome, Inc.
OCULOcular Therapeutix, Inc.
SRPTSarepta Therapeutics, Inc.
SLDBSolid Biosciences Inc.